Sign in
Taking peopleNo phase

Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia - ToolCAP

Key facts

Who runs it
Ecole Polytechnique Fédérale de Lausanne
Where
Senegal, South Africa, and Tanzania9 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
4,894 people, planned
Started
4 Apr 2025
Expected to end
31 Aug 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Lung ultrasound
  • Standard of Care (SOC)
Record updated
5 October 2026

Who can take part

Age
60 days to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Cough OR Difficulty Breathing AND,
  • One of the below:; Fast breathing (tachypnoea) > 50/minute (2-12 months) > 40/minute (1-<5 years) > 25/minute (5-12 years) OR Lower chest wall indrawing

Who cannot take part

  • Received antibiotic treatment for more than 48 hours at the time of enrolment
  • HIV positive participant that is either i) less than 12 months old; OR ii) requires admission for this illness; OR iii) known to be uncontrolled on treatment (with a documented VL >1000c/ml in the previous 6 months)
  • Presenting for repeat visit/follow-up of a treated lower respiratory tract infection (index illness / non-acute) or enrolled in the study within the preceding 28 days
  • WHO IMCI danger signs (inability to drink/breastfeed, vomiting everything, convulsions with this illness, lethargy/unconscious)
  • Underlying disease associated with increased risk of severe pneumonia or pneumonia of unusual aetiology (e.g., WHO acute malnutrition requiring antibiotics as per local guidelines, severe immunodeficiency)
  • Presence of jaundice
  • Hypoxaemia with oxygen saturation (SpO2) <88%
  • Oxygen saturation (SpO2) <90% (or country-specific / altitude-adjusted thresholds) i) With signs of severe respiratory distress (such as nasal flaring, grunting, etc.) OR ii) In children < 6 months
  • Requiring non-invasive ventilatory support (i.e., high-flow, bilevel positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP))
  • Caregiver unavailable at the time of enrolment, or unwilling, to provide informed consent

This trial is currently available in Senegal, South Africa, and Tanzania.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The ToolCAP study aims to see if using ultrasound to look at the lungs when children have symptoms of a lung infection will safely allow doctors to improve how they treat those infections. The study will also look at if it's possible to improve how doctors decide which children need antibiotics.

Read full original descriptionShow less

* Lung infections are the most common reason for children to go to the clinic/hospital. * Doctors usually give an antibiotic to every child with a lung infection. * Lung infections can be caused by 2 different types of germs - bacteria or viruses. * Antibiotics only work against bacteria and not against viruses. Lung infections caused by viruses don't need antibiotics as the body fights them by itself. * Lots of research now shows that only 1 in 4 children with a lung infection actually needs an antibiotic, as the rest only have a viral infection causing the symptoms. * This means that 3 in 4 children get an antibiotic when they don't need it. * Taking too many antibiotics can cause problems for children as it can cause diseases like diabetes or asthma. * Nowadays, due to too many people using too many antibiotics, experts are starting to worry that bacteria are starting to become resistant (stronger than the antibiotic). * Ultrasound of the lungs appears to be a way of safely looking at the lungs to see if there is an infection and may help doctors better decide who needs an antibiotic.

This study includes children aged 2 months-12 years who come to the hospital with a lung infection. Children who are very unwell or who have already had 2 days of antibiotic treatment will not be allowed to be in the study.

The 2 groups in the trial

  • Routine Care GroupExisting treatment, for comparison

    This group receives normal routine care. No intervention.

    Treatment: Standard of Care (SOC)

  • Intervention GroupTreatment being tested

    Participants will undergo lung ultrasound and the ultrasound images/videos will be reviewed by an expert and the findings, along with advice on whether or not an antibiotic should be used. This means in this group there is a chance the participant will not be given an antibiotic if the ultrasound shows there is no need for it.

    Treatment: Lung ultrasound

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ToolCAP: Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia
Record updated
5 October 2026